Chapters

Transcript

Video

Should lipidologists consider other markers such as apoB as well as LDL-C for reducing CV risk in diabetes and hypertriglyceridemia?

Should lipidologists consider other markers such as apoB as well as LDL-C for reducing CV risk in diabetes and hypertriglyceridemia?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Alberico Catapano, PhD

Alberico Catapano, PhD

Full Professor of Pharmacology

University of Milano

Director, Laboratory for the Study of Lipoproteins and Atherosclerosis

Director, Center for the Study of Atherosclerosis of the Italian Society of Atherosclerosis